glp-1 concerns Nutritional Side Effects of Drugs: Deficiencies, Muscle Loss, and What to Monitor Part 2 of a 3-Part

Understanding the differences between these options can help you make informed choices about your care

The automated verification process requires minimal oversight while maintaining effective controls

In animal models of diabetes, the authors show that co-administration of a lipid-lowering drug with a dipeptidyl peptidase-4 inhibitor or a glucagon-like peptide-1 agonist improved glucose tolerance and beta cell mass

Here is a clear-eyed overview of where the evidence stands across the three peptides most relevant to PMOS

The popularity of Wegovy, Mounjaro and Ozempic on social media platforms is spurring real-world effects